PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
58.53
ESG score 80-90% of EYEN's 72.73. Walter Schloss would scrutinize governance quality and regulatory exposure.
57.10
Environmental score below 80% of EYEN's 72.71. Jim Chanos would check for potential stranded asset risks and carbon liabilities.
59.22
Social score 80-90% of EYEN's 67.24. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
59.26
Governance score below 80% of EYEN's 78.24. Jim Chanos would check for potential agency conflicts and oversight failures.